Related Experiment Video
Updated: Jul 18, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
CMTM8 induces caspase-dependent and -independent apoptosis through a mitochondria-mediated pathway
Caining Jin1, Ying Wang, Wenling Han
1Center for Human Disease Genomics, Peking University, Beijing, PR China.
Abstract:
The mitochondria-mediated apoptotic pathway is regulated by members of the Bcl-2 family. Epidermal growth factor (EGF) induces Bad phosphorylation at Ser112 via mitogen-activated protein kinase (MAPK), impairing its binding to Bcl-2 and Bcl-xL and interfering with their anti-apoptotic functions. In the current study, we utilized Western blot, immunofluorescence, flow cytometry, and confocal microscopy to examine the effects of CMTM8 overexpression on apoptosis. Our data indicated levels of Bad-S112 phosphorylation were lower in CMTM8-transfected cells compared to pCDB-transfected cells. Caspase-dependent and independent mediated apoptosis, induced by CMTM8 overexpression, was facilitated by the mitochondria and inhibited by knockdown of Bad or overexpression of Bcl-xL. Previous research in our laboratory also demonstrated CMTM8 attenuated EGFR-mediated signaling pathways by decreasing ERK1/2 phosphorylation levels. These data implicate CMTM8 as a negative regulator of EGF-induced signaling, with potential use as a novel therapeutic gene for EGFR-targeted anticancer gene therapy.
Insights
CMTM8 overexpression reduces Bad phosphorylation, promoting apoptosis. This suggests CMTM8
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Mitochondria-mediated apoptosis is regulated by Bcl-2 family proteins.
- Epidermal growth factor (EGF) signaling impacts apoptosis via Bad phosphorylation.
- EGF receptor (EGFR) pathways are implicated in cancer progression.
Purpose of the Study:
- To investigate the role of CMTM8 in apoptosis regulation.
- To determine the effect of CMTM8 on EGF-induced signaling pathways.
- To explore CMTM8 as a potential therapeutic gene for EGFR-targeted anticancer therapy.
Main Methods:
- Western blot analysis
- Immunofluorescence microscopy
- Flow cytometry
- Confocal microscopy
Main Results:
- CMTM8 overexpression decreased Bad-S112 phosphorylation.
- CMTM8-induced apoptosis involves mitochondria and is regulated by Bad and Bcl-xL.
- CMTM8 attenuated EGFR-mediated signaling by reducing ERK1/2 phosphorylation.
Conclusions:
- CMTM8 acts as a negative regulator of EGF-induced signaling.
- CMTM8 facilitates mitochondria-mediated apoptosis.
- CMTM8 holds potential as a therapeutic gene for EGFR-targeted anticancer therapy.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Caspases
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
MAPK Signaling Cascades

